This site is easier to read in landscape format on mobiles.

Lancaster University Public Lecture Series / Darknet drug markets: in search of the bad guys

cryptomarket.jpg

Darknet drug markets: in search of the bad guys
Darknet drug markets: in search of the bad guys
Date: 
Thursday, June 6, 2019 - 18:30 to 20:00
Venue: 
The Storey, Auditorium Room, Meeting House Lane, Lancaster LA1 1TH
Performers: 
Professor Judith Aldridge
Organisers: 
Lancaster University Public Events

Darknet drug markets: in search of the bad guys


Event details


While we have witnessed some important changes in dominant political and policy discourses around drug users in recent decades – as evidenced for example in the growth of harm reduction approaches – the myths, stereotypes and moral condemnation of drug suppliers have remained mostly unchallenged.

Cryptomarkets – aka ‘darknet’ drug markets – are online but ‘hidden’ marketplaces that allow drug sellers and buyers to transact anonymously yet in plain sight of law enforcement. To the extent that drug cryptomarkets are designed – and actually function – as self-regulating eco-systems, we are, arguably, encouraged to revisit policies and practices that cast drug supply activity as morally reprehensible and exclusively harm-producing; indeed, the eradicable cause of the 'drug problem’.

In this lecture, Professor Aldridge evaluates the relative harms and benefits of the online drug trade compared to traditional offline drug buying and selling. She explains why criminologists and policy makers should pay attention to cryptomarkets as an important criminal innovation.

Date: Thursday 6th June 2019
Time: 6.30pm to 8.00pm, doors open at 6pm
Venue: The Storey, Auditorium, Lancaster


Doors open at 6pm for tea and coffee, and the talk begins at 6.30pm with the opportunity to ask questions afterwards.

To register for your free tickets, please go to Eventbrite or email public-events@lancaster.ac.uk for more details.

 

About Professor Aldridge


Professor Judith Aldridge is Professor of Criminology in the School of Law at the University of Manchester. Her research is focused on drug markets, policy and use. Over the last five years she has pioneered research in the area of ‘virtual drug markets’, culminating in the first publication connected to drug sales on ‘Silk Road’.

She co-edited a special issue of the International Journal of Drug Policy. In connection to this work, she has acted in advisory/expert capacity to agencies including the Pompidou Group of the Council of Europe, the European Monitoring Centre for Drugs and Drug Abuse (EMCDDA), and the European Commission.

 

: